Zhejiang Realsun Chemical Co. Ltd. (301212) fair value: what the stock is really worth
As of Nov 4, 2026: fair value (intrinsic value) of Zhejiang Realsun Chemical Co. Ltd. stock ¥4.36, price ¥20.95, that is 79.2% below the price, quality 55 out of 100. Rating: strongly overvalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with oneYes, for free
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 4, 2026.
How to read this chart
55‑month range ¥14.23 – ¥55.85 · fair‑value band ¥3.16 – ¥5.46 · the ¥20.95 price screens above the ¥4.36 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 4, 2026.
Follow Zhejiang Realsun Chemical Co. in your weekly email
Every Wednesday you see whether Zhejiang Realsun Chemical Co. is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Zhejiang Realsun Chemical Co.,Ltd. engages in the research and development, production, and sales of fine chemicals products in China. It also offers pharmaceutical intermediates, pesticide intermediates, electronic chemicals, and chemical solvents.
Show moreShow less
In addition, the company provides new materials, such as polybutylene succinate, PBAT, Thermoplastic polyester elastomer, polybutylene terephthalate, ethyl propionate, propyl propionate, methyl propyl carbonate, methyl ethyl carbonate, dimethyl carbonate, and diethyl carbonate; and various fine chemicals.
The company was founded in 2007 and is based in Linhai, China. Zhejiang Realsun Chemical Co.,Ltd. operates as a subsidiary of Liansheng Chemical Group Co., Ltd.
Stock analysis
Zhejiang Realsun Chemical Co. Ltd. (301212) currently trades at ¥20.95, while our model-based Fair Value estimate is ¥4.36, 79% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Economic Profit group reads highest at a median of ¥3.05 per share, and 1 of the 15 models we run sit above the ¥20.95 price.
Bear case: the Dividend Discount group reads lowest at ¥1.33, and 14 of the 15 models stay below the price. Data coverage for this calculation is low.
Scenario range: ¥3.16 (bear) to ¥5.46 (bull), the price of ¥20.95 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 55/100 (solid quality), in the Basic Materials sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Zhejiang Realsun Chemical Co. Ltd. reported revenue of 693M CNY in FY2025 versus 833M CNY in FY2021, a compound −4.5%/yr. Reported net income was 13.9M CNY in FY2025, compounding −37.1%/yr from FY2021.
Key figures
Market cap 2.3B CNY (≈ $340M) Small · P/E ratio 149.6 · P/S ratio 2.98 · EPS (TTM) ¥0.1400 · Dividend yield 0.5% · Net margin 2.0% · Return on equity 1.4% · Return on assets (EBIT) 5.9%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 34 out of 100 (medium confidence).
What moves the price
The share trades about 40% below its 52-week high and 10% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Basic Materials peers we cover trades at −41% fair-value upside, at −79%, 301212 screens richer than that median.
Fair Value models
The price assumes far more growth than our models allow for, so the models scatter widely (¥0.4400 to ¥34.98). Read the Fair Value as a cautious anchor, not a price target; the Growth Forecast section shows what the price assumes.
Bear¥3.16Fair Value ¥4.36Bull¥5.46
Price ¥20.95 · Downside -79.2%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (¥0.0322 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
Residual Income¥7.20¥7.55¥8.1276
ROIC Compounder¥2.94¥3.05¥3.1572
EPV¥2.94¥3.05¥3.1571
All 15 models by family
Earnings-Based
Graham-Dodd¥0.8700¥1.93¥2.4666
PEG = 1.0¥0.3100¥0.4400¥0.580057
EPV¥2.94¥3.05¥3.1571
Dividend Discount
Gordon GGM¥0.9600¥1.43¥1.8869
DDM Multi-Stage¥0.9600¥1.33¥1.6967
Multiples
P/E Multiple¥1.64¥2.18¥2.7363
P/S Multiple¥1.64¥2.18¥2.7358
P/B Multiple¥26.23¥34.98¥43.7255
EV/EBIT¥0.8600¥1.30¥1.7465
EV/EBITDA¥3.49¥4.80¥6.1267
EV/Revenue¥0.6800¥1.17¥1.6752
Asset-Based
NCAV (Graham)¥1.58¥2.40¥3.0054
Economic Profit
Residual Income¥7.20¥7.55¥8.1276
ROIC Compounder¥2.94¥3.05¥3.1572
Growth Earnings
Growth-Adj P/E¥1.24¥1.76¥2.2967
The fair value above starts from this blend and is adjusted for a cyclical trough year.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.20/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
+9.6%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−12.7%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+0.4%
Start year 2020 (pandemic)
Revenue growth 6 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+4.1%
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
−34.4%
Earnings growth per share plus dividend.
Earnings per share, growth per year−34.9%
Dividend (yield on the price)0.5%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.20% → 2%
Compare Zhejiang Realsun Chemical Co. Ltd. with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 728 stocks
Beats the industry median on 3/13 measures
Overall it trails its industry peers.
Valuation
Quality Score55 · Above median
Fair Value upside−79.2% · Bottom 25%
Profitability
Return on equity (12 months)1.4% · Bottom 25%
Return on assets0.8% · Below median
Net margin (12 months)2.0% · Below median
Operating margin (12 months)7.2% · Below median
Growth and dividend
Revenue growth (quarter YoY)33.2% · Top 25%
Dividend yield (12 months)0.5% · Bottom 25%
Balance sheet
Debt / equity0.02× · Below median
Valuation Multiplesvs Specialty Chemicals median · lower = cheaper
P/E (12 months)149.6× · Priciest 25%
P/B1.69× · Pricier than median
P/S (12 months)2.98× · Priciest 25%
EV/EBITDA29.5× · Priciest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 0
FUTURE (revenue growth)100· sector 65
PAST (return on equity)5· sector 26
HEALTH (low debt)99· sector 95
DIVIDEND (yield)10· sector 31
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Zhejiang Realsun Chemical Co. Ltd. Fair Value". https://www.fairvalue-calculator.com/stock/301212
Frequently asked questions
Is Zhejiang Realsun Chemical Co. Ltd. (301212) overvalued or undervalued?
As of Nov 4, 2026, our model estimates a fair value of ¥4.36 versus a price of ¥20.95, about 79% lower (overvalued).
What is the fair value of 301212?
Our model-based fair value for Zhejiang Realsun Chemical Co. Ltd. is ¥4.36 (as of Nov 4, 2026), built from audited fundamentals. The current price: ¥20.95.
What is the quality score of 301212?
Zhejiang Realsun Chemical Co. Ltd. has a Quality Score of 55/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Zhejiang Realsun Chemical Co. Ltd. (301212)?
Our model-based price target is the fair value of ¥4.36 (as of Nov 4, 2026) from 15 valuation models. Cautious scenario ¥3.16, optimistic scenario ¥5.46. It is a calculation from audited fundamentals, not an analyst target.
What is the Zhejiang Realsun Chemical Co. Ltd. stock forecast for 2026?
Our models put fair value at ¥4.36, about 79% lower versus a price of ¥20.95 (overvalued). Cautious scenario ¥3.16, optimistic scenario ¥5.46. The calculation is refreshed regularly with new filings.
What is the revenue of Zhejiang Realsun Chemical Co. Ltd. (301212)?
Zhejiang Realsun Chemical Co. Ltd. reported trailing-twelve-month revenue of about 758M CNY (latest available figure, as of Nov 4, 2026).
Does Zhejiang Realsun Chemical Co. Ltd. pay a dividend?
Zhejiang Realsun Chemical Co. Ltd. currently shows a dividend yield of 0.49% relative to its recent price (as of Nov 4, 2026).
What is the intrinsic value of Zhejiang Realsun Chemical Co. Ltd. (301212)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Zhejiang Realsun Chemical Co. Ltd. it is ¥4.36 per share (as of Nov 4, 2026), against a price of ¥20.95. It is the blended result of 15 valuation models (cash flow, earnings, asset, dividend).
Is Zhejiang Realsun Chemical Co. Ltd. stock overvalued or undervalued in 2026?
As of Nov 4, 2026, 301212 trades above its calculated fair value: price ¥20.95, fair value ¥4.36, a gap of about −79% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 301212?
No. The price is what the market pays today (¥20.95); the fair value is what the company's own numbers justify (¥4.36). For Zhejiang Realsun Chemical Co. Ltd. the two are ¥16.59 per share apart. That gap is exactly why we show both numbers side by side.
How much is Zhejiang Realsun Chemical Co. Ltd. worth?
The market values Zhejiang Realsun Chemical Co. Ltd. at about 2.3B CNY (market capitalisation, as of Nov 4, 2026). Per share that is ¥20.95; our models calculate a fair value of ¥4.36 per share.
What do the bullish and bearish scenarios say about 301212?
Our models span a range for Zhejiang Realsun Chemical Co. Ltd.: cautious scenario ¥3.16, base ¥4.36, optimistic ¥5.46 per share (as of Nov 4, 2026, price ¥20.95). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 301212?
Zhejiang Realsun Chemical Co. Ltd. trades at a price-to-earnings ratio of 149.6 (as of Nov 4, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ¥4.36 is built from several models across several years. Other multiples: P/B 1.7, P/S 3.0, EV/EBITDA 29.5.
How solid is the balance sheet of Zhejiang Realsun Chemical Co. Ltd. (301212)?
Balance-sheet figures for Zhejiang Realsun Chemical Co. Ltd. (as of Nov 4, 2026): return on equity 1.4%, debt of 0.02 per unit of equity. They feed the Quality Score of 55/100, which measures business quality independently of the share price.
How far is 301212 from its 52-week high?
Zhejiang Realsun Chemical Co. Ltd. trades at ¥20.95, about 40% below its 52-week high of ¥34.88 and 10% above the low of ¥19.07 (as of Nov 4, 2026). Distance from the high says nothing about value: that is what the fair value of ¥4.36 is for.
Which stocks are comparable to Zhejiang Realsun Chemical Co. Ltd.?
From the same area (Basic Materials) we also value Linde plc, Ecolab Inc, The Sherwin-Williams Company, Nan Ya Plastics Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Zhejiang Realsun Chemical Co. Ltd. stock attractive at the current price?
The data as of Nov 4, 2026: price ¥20.95, calculated fair value ¥4.36 (−79%), Quality Score 55/100, from 15 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 301212 calculated?
We run Zhejiang Realsun Chemical Co. Ltd. through 15 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ¥4.36, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 15.0% above its aggregate fair value. Zhejiang Realsun Chemical Co. Ltd. itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Zhejiang Realsun Chemical Co. Ltd. (301212)?
The closing price on Nov 4, 2026 was ¥20.95. Our model-based fair value is ¥4.36, about 79% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Zhejiang Realsun Chemical Co. Ltd. right now?
The price sits above even our optimistic bull case (¥5.46). The favourable scenario is already priced in. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid but not exceptional quality (55/100) and above fair value, neither a clear bargain nor a standout compounder.
Key figures of Zhejiang Realsun Chemical Co. Ltd.
How large is the market capitalisation of Zhejiang Realsun Chemical Co. Ltd. (301212)?
The market capitalisation of Zhejiang Realsun Chemical Co. Ltd. is 2.3B CNY (≈ $340M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Zhejiang Realsun Chemical Co. Ltd. (301212)?
The price-to-sales ratio of Zhejiang Realsun Chemical Co. Ltd. is 2.98 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Zhejiang Realsun Chemical Co. Ltd. (301212)?
Earnings per share at Zhejiang Realsun Chemical Co. Ltd. are ¥0.1400 (price ÷ EPS = P/E 149.6). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Zhejiang Realsun Chemical Co. Ltd. (301212)?
The dividend yield of Zhejiang Realsun Chemical Co. Ltd. is 0.5% (payout 72.9%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Zhejiang Realsun Chemical Co. Ltd. (301212)?
The net margin of Zhejiang Realsun Chemical Co. Ltd. is 2.0% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Zhejiang Realsun Chemical Co. Ltd. (301212)?
The return on equity (ROE) of Zhejiang Realsun Chemical Co. Ltd. is 1.4% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Zhejiang Realsun Chemical Co. Ltd. (301212)?
On an EBIT basis the return on assets of Zhejiang Realsun Chemical Co. Ltd. is 5.9% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Zhejiang Realsun Chemical Co. Ltd. (301212)?
The operating margin of Zhejiang Realsun Chemical Co. Ltd. is 7.2% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Zhejiang Realsun Chemical Co. Ltd. (301212)?
Revenue at Zhejiang Realsun Chemical Co. Ltd. is growing +33.2% versus a year earlier (3y avg −12.7%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Zhejiang Realsun Chemical Co. Ltd. (301212)?
Earnings per share at Zhejiang Realsun Chemical Co. Ltd. are growing +72.4% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Zhejiang Realsun Chemical Co. Ltd. (301212) generate?
The free cash flow of Zhejiang Realsun Chemical Co. Ltd. is −44.4M CNY (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Zhejiang Realsun Chemical Co. Ltd. (301212) carry?
The net debt of Zhejiang Realsun Chemical Co. Ltd. is 51.0M CNY (fiscal year 2020). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Zhejiang Realsun Chemical Co. Ltd. in the live analysis
One click puts Zhejiang Realsun Chemical Co. Ltd. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Thin data
Nov 4, 2026